Director/PDMR Shareholding

20 July 2011

Synergy Health plc ("Synergy" or the "Company")

Director/PDMR Shareholding

The Company was notified that Glenn Thibault CEO Synergy Health Americas, has purchased 9,500 ordinary shares of 0.625p each in the Company ("Ordinary Shares") at a price of 937.00 pence per share, and has allocated these shares to the LTIP Co-Invest scheme. As such, Glenn Thibault has been awarded 19,000 LTIP Co-Invest options. Following this transaction, Mr Thibault has an interest in 9,500 Ordinary Shares, representing 0.017 % of the Company's issued share capital.

The LTIP Co-Invest arrangement requires that the participant to whom the award is to be made invests in Ordinary Shares in the Company and continues to hold those Ordinary Shares throughout the three year measurement period. At the end of the measurement period, depending upon the growth in earnings per share of the Company over the measurement period, the participant will receive a number of "matching" shares at nominal value under the LTIP Co-Invest.

Enquiries

Tim Mason

Company Secretary

01793 891862